Merck (MRK) – Insiders' Blog
-
Pharma Stocks Drop After Trump Tweets Drug Prices Will 'Come Way Down!' (IBB)
-
Complete Donald Trump Stock Impact Guide
-
Investors find safety in J&J shares, but run could stall
-
Relypsa (RLYP) Takeover Rumors Turn the Tables on Short Sellers
-
Gilead Sciences (GILD) on Watch After Merck (MRK) Prices Hep C Combo
-
Meet Your 2016 Dogs of the Dow
-
Merck (MRK) Said to be Interested in Relypsa (RLYP) - Source
-
Exclusive - Transatlantic divide: how U.S. pays three times more for drugs
-
WHO Gives Nod for Two Ebola Vaccine Trials in Liberia (NLNK) (MRK) (GSK)
-
NewLink Genetics (NLNK), Merck (MRK) Ebola Vaccine Trial to Resume at Lower Dosage
-
Meet Your 2015 Dogs of the Dow
-
Meet Your 2014 Dogs of the Dow
-
Recnt Dip in Allergan (AGN) Shares Might Have Bidders Lining Up (GSK) (MRK)
-
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
-
Merck (MRK) to Further Streamline R&D Unit; Job Cuts Planned
-
Tesaro (TSRO) Faces Near-Term Risks to Key Drug - Report
-
Mitigated Patent Risks, Strong Pipeline Bode Well for Merck (MRK) - Cramer
-
Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
-
Meet Your 2013 Dogs of the Dow
-
After Years Spent Living in the Shadows, Achillion (ACHN) Becomes Belle of the Ball
-
Merck (MRK) Ticks Higher Following Positive Odanacatib Phase III News
-
Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China
-
Gilead (GILD) Issues Strong '7977 Update, Shares Move Higher
-
Merck (MRK) Has Attractive Dividend, Growth Potential - Barron's
-
Merck (MRK) Shares See Pressure on Vorapaxar Study Adjustments
-
Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
-
Q3 Preview: Merck (MRK) Trading Strong Into Earnings, Looks to Nearly Double-Up Revs Y/Y (PFE, GSK, SNY)
-
Comments From a Feverish Bull Ignites Stocks
-
Tepper's Appaloosa Increases Exposure to Big Pharma, Reduces Risk in Financials (C, BAC, MRK, PFE, More...)
-
T2's Tilson Makes the Case For Blue Chips: Anheuser-Busch (BUD), Microsoft (MSFT) and BP (BP)
-
Alcoa (AA) Kicks Off Q2 Earnings Season, Big Names to Follow (AAPL, GE, JPM, C, More...)
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Tepper's Appaloosa Cuts Stakes In Bank Stocks (BAC, C, WFC), Enters Pharmaceutical and Energy Stocks
-
Drug Makers Higher On Health Care Reform (PFE, MRK, TEVA, more...)
-
Health Care Investors Get What They Wanted: A Brown Win In Massachusetts
-
Health Care Stocks Jump On Expectations for Republican Upset In Massachusetts (HUM, UNH, PFE, more...)
-
While Attention Is on a Pfizer (PFE) Dividend Raise, Merck (MRK) Could Be Ripe for a Hike Too - Analyst
-
Eli Lilly (LLY) Down on Convction Sell, Merck (MRK) Up On Conviction Buy
-
Merck & Co. (MRK) Slammed On Speculation After Trial Abruptly Halted
-
Spring Brings 'Green Shoots' For Stocks
-
So Obama is President... Now What? Here Are Some Investment Ideas..
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
Gates' The Bill and Melinda Gates Foundation Shows New Positions in Crocs (CROX), Dick's (DKS) and Raised Stakes in McDonald's (MCD), FedEx (FDX) and AIG (AIG)
-
Merck (MRK) Lower After UBS Cuts Their Rating to Neutral
-
What's Steven Cohen's SAC Capital Buying? A Few Banks Among Other Things (BK, C)
-
Summary of JANA Partners 13F; New Stakes in AAPL, CROX, RAI, MSFT, MF, FMCN, Ups Stake in CSCO, FCX
-
Merck (MRK) Sinks On FDA Not Approvable Letter on CORDAPTIVE
-
Jim Cramer Is A Seller of Google (GOOG)--'Contrary Indicator'?
-
Major Drug Companies Fall to New 52-Week Lows (PFE, GSK, MRK, LLY, BMY)
-
Summary of Jana Partners 13F; New Stakes in AA, APC, BEAS, CNET, Ups Stake in YHOO
Back to MRK Stock Lookup
